TOL.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:24):

Stats
Today's Volume	210 447
Average Volume	139 558
Market Cap	110.09M
EPS	SEK-0.00963 ( 2023-09-30 )
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-7.13
ATR14	SEK0.00700 (1.40%)

Toleranzia AB Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Toleranzia AB Financials

Annual	2023
Revenue:	SEK51.27M
Gross Profit:	SEK51.24M (99.95 %)
EPS:	SEK-0.0560

Q4	2023
Revenue:	SEK11.42M
Gross Profit:	SEK11.42M (99.95 %)
EPS:	SEK-0.00970

Q3	2023
Revenue:	SEK10.01M
Gross Profit:	SEK19.80M (197.87 %)
EPS:	SEK-0.00960

Q2	2023
Revenue:	SEK19.66M
Gross Profit:	SEK39.32M (200.00 %)
EPS:	SEK-0.0227

Financial Reports:

No articles found.

Toleranzia AB

Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also intends to develop TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. In addition, the company develops tolerogens technology, a treatment method that creates disease-specific tolerance in the immune system for treating various autoimmune diseases. The company was founded in 2011 and is headquartered in Gothenburg, Sweden.